Description | TrkAisamemberoftheneurotrophictyrosinekinasereceptorfamily.Itisamembrane-boundreceptorthatuponneurotrophinbinding,phosphorylatesitselfandmembersoftheMAPKpathway.TrkAisrequiredforhigh-affinitybindingtonervegrowthfactor(NGF),neurotrophin-3andneurotrophin-4/5butnotbrain-derivedneurotrophicfactor(BDNF).TrkAleadstocelldifferentiationsandmayplayaroleinspecifyingsensoryneuronsubtypes.Ithasacrucialroleinthedevelopmentandfunctionofthenociceptivereceptionsystemaswellasestablishmentofthermalregulationviasweating.SUBUNIT:Existsinadynamicequilibriumbetweenmonomeric(lowaffinity)anddimeric(highaffinity)structures.SUBCELLULARLOCATION:TrkAisaheavilyglycosylatedtransmembraneproteinandcontains13potentialN-linkedglycosylationsites.TheTrkA-FcchimerahasN-linkedandmayhaveO-linkedoligosaccharides. |
BatchNo. | Seeproductlabel |
Unitsize | 100µg |
OtherNames | Tropomyosin-relatedkinasereceptor;Highaffinitynervegrowthfactorreceptor;Neurotrophictyrosinekinasereceptortype1;TRK1transformingtyrosinekinaseprotein;p140-TrkA;Trk-A;NTRK1;TRK |
Accession | P04629NTRK1_HUMAN; |
Producedin | Human-ADNAsequenceencodingthesignalpeptideandextracellulardomainofhumanTrkA(aminoacids1-413)wasfusedtotheFcregionofhumanIgG1(aminoacids104-330).Thechimericproteinwasexpressedinmodifiedhuman293cells. |
MolecularWeight | TheTrkA-Fcchimeramigratesasabroadbandbetween90and120kDainSDS-PAGEunderreducingconditionsduetopost-translationalmodifications,inparticularglycosylation.TheunmodifiedTrkA-Fcchimerathathasapredictedmolecularmassof70.2kDaandpredictedpIof5.8.Undernon-reducingconditions,TrkA-Fcmigratesasabroadbandbetween180and240kDademonstratingtheexistenceofthisproteinasadimer.Asecond,lessintensebandisobservedat140kDaundertheseSDS-PAGEconditions,suggestingthepresenceofnon-glycosylatedTrkA-Fcisoforms. |
Purity | >95%,asdeterminedbySDS-PAGE. |
Form | ProteinGpurified. |
Reconstitution | Spinvialbrieflybeforeopening.Reconstitutein200uLsterilePBS,pH7.4togiveaconcentrationof0.5mg/mL. |
Storage | Lyophilizedproductsshouldbestoredat2to8°C.Followingreconstitution,short-termstorageat4°Cisrecommendedandlonger-termstorageofaliquotsat-18to-20°C.Repeatedfreezethawingisnotrecommended. |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。